Inflammatory conditions remain a major focus of modern healthcare, driving demand for effective therapies that help relieve pain, reduce inflammation, and improve patient well-being. Active pharmaceutical ingredients such as Etofenamate, Flufenamic Acid, and Mefenamic Acid are widely used for their anti-inflammatory and analgesic properties in the treatment of musculoskeletal and inflammatory disorders. Domiphen is recognized for its antimicrobial applications in healthcare formulations, while Erythromycin Cyclocarbonate, a macrolide antibiotic derivative, supports the management of infections associated with inflammatory conditions. Drawing on more than 50 years of expertise in pharmaceuticals and fine chemicals, Zhejiang Haizhou Pharmaceutical supplies high-quality APIs, intermediates, and custom manufacturing solutions to pharmaceutical partners worldwide. Supported by cGMP-compliant facilities, robust quality systems, and international regulatory approvals, Haizhou Pharm helps customers develop reliable anti-inflammatory and therapeutic products that meet the highest standards of quality, safety, and performance.